CCNG1 and cancer: Mechanistically, inhibiting CCNG1 disrupts the Cyclin G1/Cdk2/Myc/Mdm2/p53 Axis of executive oncogenes, a critical regulatory pathway governing cell survival, growth, and proliferation, inducing cell cycle arrest and apoptosis of cancer cells [22,23].